A major milestone on the way to this goal is the definition of breast cancer molecular subtypes based on gene expression profiles: Basal-like [1], LuminalA, LuminalB, HER2-enriched and Normal-like [2–5], which are used in PAM50 [6]. Here, ERBB2 is linked to breast carcinoma.